perphenazine has been researched along with methylphenidate in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (35.71) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boulouard, M; Bureau, R; Butt, S; Dauphin, F; Dumuis, A; Hinschberger, A; Lelong, V; Pfeiffer, B; Rault, S; Renard, P | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Boulouard, M; Bureau, R; Butt-Gueulle, S; Dauphin, F; Daveu, C; Duchatelle, P; Dumuis, A; Lelong-Boulouard, V; Lemaître, S; Lepailleur, A; Lezoualc'h, F; Pfeiffer, B; Rault, S | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Huapaya, LV | 1 |
| Ban, TA; Noe, W; St Jean, A; Sterlin, C | 1 |
| Rappaport, M | 1 |
| Fann, WE | 1 |
| HAYS, GB; LYLE, CB; WHEELER, CE | 1 |
1 review(s) available for perphenazine and methylphenidate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for perphenazine and methylphenidate
| Article | Year |
|---|---|
Clinical studies with propericiazine (R.P. 8909).
Topics: Acute Disease; Adolescent; Adult; Aged; Association; Behavior; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Drug Synergism; Epilepsy; Female; Flicker Fusion; Humans; Imipramine; Injections, Intramuscular; Intellectual Disability; Male; Mental Disorders; Methylphenidate; Middle Aged; Nicotinic Acids; Perphenazine; Phenobarbital; Phenothiazines; Promethazine; Psychological Tests; Psychophysiology; Reaction Time; Schizophrenia; Thioridazine; Tranquilizing Agents; Tranylcypromine; Trifluoperazine | 1967 |
12 other study(ies) available for perphenazine and methylphenidate
| Article | Year |
|---|---|
New benzo[h][1,6]naphthyridine and azepino[3,2-c]quinoline derivatives as selective antagonists of 5-HT4 receptors: binding profile and pharmacological characterization.
Topics: Animals; Behavior, Animal; Chlorocebus aethiops; COS Cells; Cyclic AMP; Guinea Pigs; Lethal Dose 50; Male; Maze Learning; Mice; Naphthyridines; Quinolines; Radioligand Assay; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Toxicity Tests, Acute | 2003 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.
Topics: Animals; Chlorocebus aethiops; COS Cells; Humans; Indoles; Models, Molecular; Molecular Structure; Pyrazines; Radioligand Assay; Serotonin 5-HT4 Receptor Antagonists; Serotonin Antagonists; Sulfonamides | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Seven cases of somnambulism induced by drugs.
Topics: Adult; Alcoholism; Amitriptyline; Chlorprothixene; Depression; Drug Therapy, Combination; Ethchlorvynol; Female; Humans; Male; Methaqualone; Methylphenidate; Middle Aged; Perphenazine; Psychotic Disorders; Secobarbital; Somnambulism | 1979 |
Attention to competing voice messages by nonacute schizophrenic patients. Effects of message load, drugs, dosage levels and patient background.
Topics: Acute Disease; Adult; Attention; Auditory Perception; Chlorpromazine; Chronic Disease; Dextroamphetamine; Electroconvulsive Therapy; Female; Humans; Information Theory; Intelligence Tests; Male; Methylphenidate; Perphenazine; Phenothiazines; Schizophrenia; Voice | 1968 |
Use of methylphenidate to counteract acute dystonic effects of phenothiazines.
Topics: Adult; Humans; Male; Methylphenidate; Movement Disorders; Perphenazine; Schizophrenia; Torticollis; Tranquilizing Agents | 1966 |
SLATE-GRAY COLOR IN PATIENTS RECEIVING CHLORPROMAZINE.
Topics: Argyria; Chlorpromazine; Chromatophores; Dermatitis, Phototoxic; Diagnosis, Differential; Drug Therapy; Face; Hand; Humans; Imipramine; Melanins; Methylphenidate; Neck; Parasympatholytics; Pathology; Perphenazine; Photosensitivity Disorders; Pigmentation Disorders; Prochlorperazine; Reserpine; Toxicology; Trifluoperazine; Trihexyphenidyl | 1964 |